Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has esta...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Sarah Kelddal, Karen Marie Nykj ær, Jon Waarst Gregersen and Henrik Birn Tags: Research article Source Type: research